Generic name: estradiol acetate
Dosage form: vaginal ring
This dosage information does not include all the information needed to use Femring safely and effectively. See full prescribing information for Femring.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be considered to reduce the risk of endometrial cancer. A woman without a uterus does not need a progestin. In some cases, however, hysterectomized women with a history of endometriosis may need a progestin.
Use of estrogen-alone, or in combination with a progestin, should be with the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Postmenopausal women should be re-evaluated periodically as clinically appropriate to determine if treatment is still necessary. (See BOXED WARNINGS and WARNINGS.)
Two doses of Femring are available, 0.05 mg/day and 0.10 mg/day, for the treatment of moderate to severe vasomotor symptoms and/or vulvar and vaginal atrophy due to menopause.
Patients should be started at the lowest dose. The lowest effective dose of Femring has not been determined.
Instructions for Use
Hands should be thoroughly washed before and after ring insertion.
Insert upon removal from the protective pouch.
The opposite sides of the vaginal ring should be pressed together and inserted into the vagina. The exact position is not critical to its function. When Femring is in place, the patient should not feel anything. If the patient feels discomfort, the vaginal ring is probably not far enough inside the vagina. Gently push Femring further into the vagina.
Femring should remain in place for 3 months and then be replaced by a new Femring.
The patient should not feel Femring when it is in place and it should not interfere with sexual intercourse. Straining upon bowel movement may make Femring move down in the lower part of the vagina. If so, it may be repositioned with a finger.
If Femring is expelled totally from the vagina, it should be rinsed in lukewarm water and reinserted by the patient (or healthcare provider if necessary).
Femring may be removed by looping a finger through the ring and pulling it out.
For patient instructions, see PATIENT INFORMATION.
- Femring Side Effects
- Femring Drug Interactions
- Alora (estradiol) transdermal system, patch dosage information
- Climara (estradiol) transdermal patch dosage information
- Climara (estradiol) consumer information
- Delestrogen (estradiol valerate) injection dosage information
- Depo-Estradiol (estradiol cypionate) injection dosage information
- Divigel (estradiol) consumer information
- Elestrin (estradiol) gel dosage information
- Elestrin (estradiol) consumer information
- Estrace (estradiol) tablet dosage information
- Estrace (estradiol) consumer information
- Estraderm (estradiol) patch, extended release dosage information
- Estradiol dosage information
- Estradiol consumer information
- Estradiol Patch transdermal patch dosage information
- Estrasorb (estradiol) consumer information
- EstroGel (estradiol) gel, metered dosage information
- Estrogel (estradiol) consumer information
- Evamist (estradiol) transdermal spray dosage information
- Evamist (estradiol) consumer information
- Femtrace (estradiol acetate) tablet dosage information
- Femtrace (estradiol) consumer information
- Menostar (estradiol) patch dosage information
- Menostar (estradiol) consumer information
- Minivelle (estradiol transdermal system) film, extended release dosage information
- Vivelle (estradiol) patch, extended release dosage information
- Vivelle-Dot (estradiol) patch, extended release dosage information